Oxford Vaccine Spike Protein

Lab Reagents

Human IgG antibody Laboratories manufactures the oxford vaccine spike protein reagents distributed by Genprice. The Oxford Vaccine Spike Protein reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Protein. Other Oxford products are available in stock. Specificity: Oxford Category: Vaccine Group: Spike Protein

Spike Protein information

SARS Spike Peptide
3219P 0.05 mg
EUR 197.7
Description: (NT) SARS Spike peptide

SARS Spike Antibody
24216-100ul 100ul
EUR 468

SARS Spike Antibody
24217-100ul 100ul
EUR 468

SARS Spike Antibody
24218-100ul 100ul
EUR 468

SARS Spike Antibody
24219-100ul 100ul
EUR 468

SARS Spike Antibody
24318-100ul 100ul
EUR 468

SARS Spike Peptide
3525P 0.05 mg
EUR 197.7
Description: (CT) SARS Spike peptide

SARS Spike Antibody
20-abx137184
  • EUR 1262.40
  • EUR 1846.80
  • EUR 2064.00
  • 100 ug
  • 200 ug
  • 300 µg

SARS Spike Antibody
20-abx137200
  • EUR 1412.40
  • EUR 2264.40
  • EUR 2665.20
  • 100 ug
  • 200 ug
  • 300 µg

Spike Glycoprotein Antibody
20-abx300551
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

MERS Spike S1 Recombinant protein
39-102 0.1 mg
EUR 556.8
Description: Since April 2012, cases of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) have been identified in the following countries: Saudi Arabia, Qatar, Jordan, the United Arab Emirates, Oman, Kuwait, Yemen, Lebanon, Iran, Algeria, the United Kingdom, France, Italy, Greece, Germany, the Netherlands, Austria, Tunisia, Egypt, Malaysia, Turkey and the United States of America. Coronaviruses are the cause of the common cold, SARS (severe acute respiratory syndrome) and other severe illnesses with high mortality rates, all are classified into coronavirus family. MERS-CoV is a new type of SARS found in the coronavirus family causing severe pneumonia with sudden and serious respiratory illness with high mortality rates as well. Since January 27th 2015, the WHO has reported 956 human cases, including 351 deaths. More cases of the new coronavirus strain are expected. Like in other coronaviruses, large surface spike glycoprotein is a central structural protein of this virus; it is located above the virion surface to bind and enter into the target cell. Spike protein has 2 domains- S1 and S2. The S1 domain is responsible for cellular tropism and interaction with target cell, while the S2 domain is responsible for membrane fusion. The C-terminal of S1 domain contains a receptor binding domain, and is also a potential target for vaccine development and an antigen for diagnosis.

SARS Spike RBD Recombinant Protein
10-211 0.1 mg
EUR 651.3
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensinconverting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

SARS-CoV spike protein Antibody
abx023139-100ug 100 ug
EUR 1028.4

SARS-CoV spike protein Antibody
abx023143-100ug 100 ug
EUR 1028.4

Rabbit Anti-West Nile Virus vaccine (WNV, Recombitek/DNA vaccine) antiserum
WNV13-S 100 ul
EUR 548.4

EcoCRM Diptheria Toxin Mutant Vaccine Carrier Protein
1601-001 1mg
EUR 363.6
Description:
  • Related to: Vaccine Adjuvant

Peptidoglycan (S. aureus); vaccine adjuvant
AV-7045-25 25 mg
EUR 1220.4